104692-9 |
Oxymorphone |
PrThr |
Saliva |
Pt |
Ord |
Screen |
|
ACTIVE |
oxyMORphone [Presence] in Saliva (oral fluid) by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
104692-9 |
|
Screen |
|
|
Both |
|
|
|
0 |
oxyMORphone Sal Ql Scn |
|
|
|
N |
|
14-Hydroxydihydromorphinone; DRUG/TOXICOLOGY; Drugs; Numorphan; Numorphone; Opana; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104693-7 |
Ethyl Glucuronide |
PrThr |
Saliva |
Pt |
Ord |
Screen |
|
ACTIVE |
Ethyl glucuronide [Presence] in Saliva (oral fluid) by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
104693-7 |
|
Screen |
|
|
Both |
|
|
|
0 |
Ethyl glucuronide Sal Ql Scn |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; EtG; Ethanol metabolite; Gluc; Glucouronide; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104694-5 |
Cells.CD40 |
PrThr |
Bld |
Pt |
Ord |
Flow cytometry |
|
ACTIVE |
CD40 cells [Presence] in Blood by Flow cytometry (FC) |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
104694-5 |
|
Flow cytometry |
|
|
Both |
|
|
|
0 |
CD40 Cells Bld Ql FC |
|
|
|
N |
|
Blood; Bp50; CD40 Cells; Cell; CELL MARKERS; Cellularity; Dynamic; FC; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104695-2 |
Aminoacylase-1 deficiency panel |
- |
Urine |
Pt |
- |
|
|
ACTIVE |
Aminoacylase-1 deficiency panel - Urine |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
104695-2 |
|
|
|
|
Order |
|
|
|
0 |
Aminoacylase-1 deficiency pnl Ur |
|
|
|
N |
|
Aminoacylase-1 deficiency pnl; Chemistry; i; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; UA; UR; Urn |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
104696-0 |
N-acetylglycine/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
N-acetylglycine/Creatinine [Molar ratio] in Urine |
|
ADD |
DefinitionDescription |
|
|
mmol/mol creatinine |
|
|
|
|
|
|
CHEM |
|
104696-0 |
|
|
|
|
Both |
|
|
|
0 |
N-acetylglycine/Creat Ur-sRto |
|
|
|
N |
|
Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.78 |
2.78 |
|
|
|
|
|
|
|
mmol/mol{creat} |
|
|
|
0 |
104697-8 |
N-acetyl-L-alanine/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
N-acetyl-L-alanine/Creatinine [Molar ratio] in Urine |
|
ADD |
DefinitionDescription |
|
|
mmol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
104697-8 |
|
|
|
|
Both |
|
|
|
0 |
N-acetyl-L-alanine/Creat Ur-sRto |
|
|
|
N |
|
Ala; Alpha alanine; Chemistry; CR; Crea; Creat; L-alanine; Left; Levo; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.78 |
2.78 |
|
|
|
|
|
|
|
mmol/mmol{creat} |
|
|
|
0 |
104698-6 |
N-acetyl-L-glutamate/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
N-acetyl-L-glutamate/Creatinine [Molar ratio] in Urine |
|
NAM |
DefinitionDescription |
|
|
mmol/mol creatinine |
|
|
|
|
|
|
CHEM |
|
104698-6 |
|
|
|
|
Both |
|
|
|
0 |
N-acetyl-L-glutamate/Creat Ur-sRto |
|
|
|
N |
|
c707; Chemistry; CR; Crea; Creat; Glu; Glutamic acid; Left; Levo; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.79 |
2.78 |
|
|
|
|
|
|
|
mmol/mol{creat} |
|
|
Release 2.79: COMPONENT: Component updated to represent srto; |
0 |
104699-4 |
N-acetyl-L-methionine/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
N-acetyl-L-methionine/Creatinine [Molar ratio] in Urine |
|
ADD |
DefinitionDescription |
|
|
mmol/mol creatinine |
|
|
|
|
|
|
CHEM |
|
104699-4 |
|
|
|
|
Both |
|
|
|
0 |
N-acetyl-L-methionine/Creat Ur-sRto |
|
|
|
N |
|
Chemistry; CR; Crea; Creat; Left; Levo; Met; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.78 |
2.78 |
|
|
|
|
|
|
|
mmol/mol{creat} |
|
|
|
0 |
1047-0 |
H NOS Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated H NOS Ab [Presence] in Serum or Plasma |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1047-0 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated H NOS Ab SerPl Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Other; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.65 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
10470-3 |
Choriogonadotropin Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Choriogonadotropin Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10470-3 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
HCG Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; CG; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.56 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
104700-0 |
Platelet clump |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Platelet clump [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104700-0 |
|
|
|
|
Observation |
|
|
|
0 |
Platelet Clump Bld Ql |
|
|
|
N |
|
Blood; HEMATOLOGY/CELL COUNTS; Ordinal; Pl; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrombocyte; Thrombocytes; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104701-8 |
Blood smear finding |
Prid |
Bld |
Pt |
Nar |
|
|
ACTIVE |
Blood smear finding [Identifier] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104701-8 |
|
|
|
|
Observation |
|
|
|
0 |
Bld Smear Interp Bld |
|
|
|
N |
|
Bld Smear Interp; Blood; HEMATOLOGY/CELL COUNTS; Identity or presence; Narrative; Point in time; Random; Report; smears; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104702-6 |
Rhinovirus+Enterovirus RNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Rhinovirus+Enterovirus RNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104702-6 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
RV+EV RNA Spec Ql |
|
|
|
N |
|
Entero virus; EV; HRV; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Rhino virus; RHV; Ribonucleic acid; RV+EV; RV+EV RNA; Screen; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104703-4 |
Medication non-substitution reason |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Medication non-substitution reason |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MEDS |
|
104703-4 |
|
|
|
|
Observation |
|
|
|
0 |
Med non-sub reason |
|
|
|
N |
|
Finding; Findings; Med non-sub reason; MEDS; Nominal; Point in time; Random |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104704-2 |
Acanthocytes |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Acanthocytes [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104704-2 |
|
|
|
|
Observation |
|
|
|
0 |
Acanthocytes Bld Ql |
|
|
|
N |
|
Acanthocyte; Blood; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spur cells; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104705-9 |
Platelets |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Platelets [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104705-9 |
|
|
|
|
Observation |
|
|
|
0 |
Platelet Bld Ql |
|
|
|
N |
|
Blood; HEMATOLOGY/CELL COUNTS; Ordinal; Platelet; Platelet adequacy; Platelet estimate; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104706-7 |
Mycoplasma pneumoniae DNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Mycoplasma pneumoniae DNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104706-7 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
M pneumo DNA Spec Ql |
|
|
|
N |
|
Deoxyribonucleic acid; Enzootic pneumonia; M pneumo; M pneumonia; M pneumoniae; Microbiology; Misc; Miscellaneous; Molecular genetics; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Ordinal; Other; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104707-5 |
Medication safety override |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Medication safety override Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MEDS |
|
104707-5 |
|
|
|
|
Observation |
|
|
|
0 |
Med safety override |
|
|
|
N |
|
Finding; Findings; Med safety override; MEDS; Narrative; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104708-3 |
Estimated average glucose |
SCnc |
Bld |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Estimated average glucose [Moles/volume] in Blood |
|
DEL |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
104708-3 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Est. average glucose Bld-sCnc |
|
|
|
N |
|
Blood; Chemistry; eAG; eAVG; Est. average glucose; Glu; Gluc; Glucose mean value; Glucoseur; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.79 |
2.78 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
104709-1 |
Parainfluenza virus 1 RNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Parainfluenza virus 1 RNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104709-1 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
HPIV1 RNA Spec Ql |
|
|
|
N |
|
HPIV; HPIV1; Human respirovirus 1; i; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10471-1 |
Chromogranin A Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Chromogranin A Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10471-1 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
CgA Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; Cg; CgA; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; Tumor marker |
2.56 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
104710-9 |
Target cells |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Target cells [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104710-9 |
|
|
|
|
Observation |
|
|
|
0 |
Targets Bld Ql |
|
|
|
N |
|
Blood; Cell; Cellularity; Codocyte; Codocytes; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Targets; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104711-7 |
Parainfluenza virus 3 RNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Parainfluenza virus 3 RNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104711-7 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
HPIV3 RNA Spec Ql |
|
|
|
N |
|
HPIV; HPIV3; Human respirovirus 3; III; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PCR; PI3; Point in time; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104712-5 |
Human coronavirus NL63 RNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Human coronavirus NL63 RNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104712-5 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
HCoV NL63 RNA Spec Ql |
|
|
|
N |
|
Corona virus; HCoV; HCoV NL63; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104713-3 |
Stomatocytes |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Stomatocytes [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104713-3 |
|
|
|
|
Observation |
|
|
|
0 |
Stomatocytes Bld Ql |
|
|
|
N |
|
Blood; Fish mouth cell; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stomatocyte; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |